Juha Laine
Professor of Practice
University of Turku
InFLAMES Flagship
I’m health economist and social scientist with 7 years of health economics research experience and over 15 years of pharma industry experience. Currently I work at Roche Finland. F. Hoffmann-La Roche AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
I was appointed 2021 as Professor of Practice in pharmacoeconomics (part-time) in the University of Turku, Finland. I also have Adjunct Professor positions at the University of Eastern Finland and University of Helsinki, Finland.
My expertise is related to real world data, effectiveness and cost-effectiveness measurement, market access, health economics, cost-effectiveness modeling, pricing & reimbursement, health technology assessment (HTA), pharmaceutical policy, price regulation, value based health care, value demonstration, performance measurement, risk-sharing contracting, healthcare environment management and scientific communication.
During the years I’ve been working with many therapeutic areas from prevention to care like vaccines, inflammation diseases, smoking cessation, anticoagulation, hemophilia, cancers, rare diseases, cardio-vascular diseases and pulmonary diseases.
I have published over 100 scientific articles, posters, discussion papers, writings and blogs. I’m been member or many local and European working groups.
I was appointed 2021 as Professor of Practice in pharmacoeconomics (part-time) in the University of Turku, Finland. I also have Adjunct Professor positions at the University of Eastern Finland and University of Helsinki, Finland.
My expertise is related to real world data, effectiveness and cost-effectiveness measurement, market access, health economics, cost-effectiveness modeling, pricing & reimbursement, health technology assessment (HTA), pharmaceutical policy, price regulation, value based health care, value demonstration, performance measurement, risk-sharing contracting, healthcare environment management and scientific communication.
During the years I’ve been working with many therapeutic areas from prevention to care like vaccines, inflammation diseases, smoking cessation, anticoagulation, hemophilia, cancers, rare diseases, cardio-vascular diseases and pulmonary diseases.
I have published over 100 scientific articles, posters, discussion papers, writings and blogs. I’m been member or many local and European working groups.
